Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01185 (
vasopressin
)
23,126
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Chlorpropamide is known to enhance the water permeability response of the toad urinary bladder to
vasopressin
and to theophylline. In other studies, we have shown that prostaglandin E synthesis by the toad bladder inhibits the water permeability response to arginine vasopressin and to theophylline. In this study, the effect of chlorpropamide on
vasopressin
-, theophylline-, and cyclic
AMP
-stimulated water flow and on prostaglandin E biosynthesis was investigated in the toad urinary bladder in vitro. Chlorpropamide inhibited prostaglandin E biosynthesis during
vasopressin
-, theophylline- and cyclic
AMP
-stimulated water flow. Tolbutamide and glyburide, two other sulfonylurea compounds, also enhanced
vasopressin
-stimulated water flow and inhibited
vasopressin
-stimulated prostaglandin E biosynthesis. We conclude that the mechanism of enhancement on
vasopressin
-stimulated water flow by the sulfonylureas is the inhibition of prostaglandin E biosynthesis.
...
PMID:Inhibition of vasopressin-stimulated prostaglandin E biosynthesis by chlorpropamide in the toad urinary bladder. Mechanism of enhancement of vasopressin-stimulated water flow. 19 21
Activity of the Na pump was judged by Na extrusion in epithelial cells loaded with Na by a previous incubation in K-free solutions in the cold. Oxytocin significantly stimulated Na extrusion either at normal (3.5 mM) or low (0.25 mM) K in the medium. It was stimulated as well by cyclic
AMP
. Maximal concentrations of either agent caused about the same degree of stimulation. Addition of ouabain or removal of K prevented the action of both agents, but amiloride showed no effect at all. These results strongly suggest that, a)
neurohypophyseal
hormones not only increase Na entry across the mucosal barrier of the epithelium but they also stimulate the serosal Na pump, b) cyclic
AMP
not only mediates the action of
neurohypophyseal
hormones on Na and water permeability of the mucosal barrier, but it also mediates the action of the hormones on the Na pump of the serosal barrier.
...
PMID:Sodium pump stimulation by oxytocin and cyclic AMP in the isolated epithelium of the frog skin. 20 19
In the toad urinary bladder 8-p-chlorophenylthio-cyclic
AMP
mimics the stimulatory effects of
antidiuretic hormone
on osmotic water permeability, 3H2O diffusion, and transepithelial sodium transport; but unlike the hormone does not cause an increase in urea permeability. Trheshold activation for the hydroosmotic response is observed at 1 micrometer and full activation at 100 micrometer. These results suggest that cyclic
AMP
may not mediate all the physiological effects of
antidiuretic hormone
and that this highly potent cyclic
AMP
analog may be useful in elucidating the precise role of cyclic
AMP
in other biomediate hormone action.
...
PMID:8-P-Chlorophenylthio-cyclic AMP: a potent partial simulator of antidiuretic hormone action. 20 61
Resistance of the chronically diseased kidney to
vasopressin
has been proposed as a possible explanation for the urinary concentrating defect of uremia. The present studies examined the water permeability and adenylate cyclase responsiveness of isolated cortical collecting tubules (CCT) from remnant kidneys of uremic rabbits to
vasopressin
. In the absence of
vasopressin
the CCTs of both normal and uremic rabbits were impermeable to water. At the same osmotic gradient, addition of a supramaximal concentration of
vasopressin
to the peritubular bathing medium led to a significantly lower net water flux per unit length (and per unit luminal surface area) in uremic CCTs than in normal CCTs. Transepithelial osmotic water permeability coefficient, P(f), was 0.0232 +/-0.0043 cm/s in normal CCTs and 0.0059+/-0.001 cm/s in uremic CCTs (P < 0.001). The impaired
vasopressin
responsiveness of the uremic CCTs was observed whether normal or uremic serum was present in the bath. Basal adenylate cyclase activity per microgram protein was comparable in normal and uremic CCTs. Stimulation by NaF led to equivalent levels of activity in both, whereas
vasopressin
-stimulated activity was 50% lower in the uremic than in the normal CCTs (P < 0.025). The cyclic
AMP
analogue, 8-bromo cyclic
AMP
, produced an increase in the P(f) of normal CCTs closely comparable to that observed with
vasopressin
. In contrast, the P(f) of uremic CCTs was only minimally increased by this analogue and was not further stimulated by theophylline. These studies demonstrate an impaired responsiveness of the uremic CCT to
vasopressin
. This functional defect appears to be a result, at least in part, of a blunted responsiveness of adenylate cyclase to
vasopressin
. The data further suggest that an additional defect in the cellular response to
vasopressin
may exist, involving a step (or steps) subsequent to the formation of cyclic
AMP
.A unifying concept of the urinary concentrating defect of uremia is proposed which incorporates a number of hitherto unexplained observations on the concentrating and diluting functions of the diseased kidney.
...
PMID:Functional profile of the isolated uremic nephron. Impaired water permeability and adenylate cyclase responsiveness of the cortical collecting tubule to vasopressin. 20 38
The antimitotic agents colchicine, podophyllotoxin, and vinblastine inhibit the action of
vasopressin
and cyclic
AMP
on osmotic water movement in the toad urinary bladder. The alkaloids have no effect on either basal or
vasopressin
-stimulated sodium transport or urea flux across the tissue. Inhibition of
vasopressin
-induced water movement is half-maximal at the following alkaloid concentrations: colchicine, 1.8 X 10(-6) M; podophyllotoxin, 5 X 10(-7)M; and vinblastine, 1 X 10(-7)M. The characteristics of the specificity, time-dependence and temperature-dependence of the inhibitory effect of colchicine are similar to the characteristics of the interaction of this drug with tubulin in vitro, and they differ from those of its effect on nucleoside transport. Inhibition of the
vasopressin
response by colchicine, podophyllotoxin, and vinblastine is not readily reversed. The findings support the view that the inhibition of
vasopressin
-induced water movement by the antimitotic agents is due to the interaction of these agents with tubulin and consequent interference with microtubule integrity and function. Taken together with the results of biochemical and morphological studies, the findings provide evidence that cytoplasmic microtubules play a critical role in the action of
vasopressin
on transcellular water movement in the toad bladder.
...
PMID:Evidence for involvement of microtubules in the action of vasopressin in toad urinary bladder. I. Functional studies on the effects of antimitotic agents on the response to vasopressin. 20 71
In vivo experiments were performed in male Wistar rats to elucidate the probable relation between renal concentrating ability and medullary cyclic
AMP
content as influenced by changes of hydration and by administration of
antidiuretic hormone
(
ADH
). Cyclic AMP levels were 37% lower in water diuretic than in control animals (P less than 0.01), but were not significantly changed during prolonged antidiuresis induced by dehydration or
ADH
administration. Nor could any change of cyclic
AMP
levels be demonstrated between 2 and 20 min after
ADH
injection. Significant increases of medullary cyclic
AMP
content occurred following stress, anesthesia, and administration of isoproterenol and 3-isobutyl-1-methylxanthin. The results suggest that the level of cyclic
AMP
in the renal medulla may not be an important determinant of the antidiuretic response produced by
ADH
in rats.
...
PMID:Dissociation between antidiuretic response and renal medullary cyclic AMP levels in the rat. 20 98
The enzyme activities of cyclic
AMP
system in the neuro- and adenohypophyses were studied, immediately after an irradiation by a single whole body exposure of 1600 R, in an attempt to find whether this intervention causes the changes in the responsiveness of the cyclic
AMP
regulatory system. In the irradiated rats the neurohypophyses revealed a reduced activity of adenylate cyclase, moderately increased activity of phosphodiesterase and slightly decreased activity of protein kinase, including the value stimulated by cyclic
AMP
. In the adenohypophyses the irradiation did not cause any significant changes in the enzyme activities of the cyclic
AMP
system, except of slightly decreased adenylate cyclase activity. The possible relationship of the plasma level of
antidiuretic hormone
immediately after irradiation and the enzyme activities of cyclic
AMP
system is discussed.
...
PMID:Effect of irradiation on enzyme activities of cyclic AMP system in the neuro- and adenohypophyses. 21 Apr 9
A 6-week-old girl with fever, hypernatraemia, dehydration, and polyuria failed to concentrate urine in response to exogenous
vasopressin
administration. There was no family history of nephrogenic diabetes insipidus. When she was 15 months old, the infusion of
vasopressin
did not produce an increase in urinary cyclic-
AMP
.
...
PMID:Congenital nephrogenic diabetes insipidus in a baby girl. 21 90
Whereas adenosine itself exerted independent stimulatory and inhibitory effects on the adenylate cyclase activity of a platelet particulate fraction at low and high concentrations respectively, 2-substituted and N6-monosubstituted adenosines had stimulatory but greatly decreased inhibitory effects. Deoxyadenosines, on the other hand, had enhanced inhibitory but no stimulatory effects. The most potent inhibitors found were, in order of increasing activity, 9-(tetrahydro-2-furyl)adenine (SQ 22536), 2',5'-dideoxyadenosine and 2'-deoxyadenosine 3'-monophosphate. Kinetic studies on prostaglandin E1-activated adenylate cyclase showed that the inhibition caused by either 2',5'-dideoxyadenosine or compound SQ 22536 was non-competitive with MgATP and that the former compound, at least, showed negative co-operativity; 50% inhibition was observed with 4 micron-2',5'-dideoxyadenosine or 13 micron-SQ 22536. These two compounds also inhibited both the basal and prostaglandin E1-activated adenylate cyclase activities of intact platelets, when these were measured as the increases in cyclic [3H]
AMP
in platelets that had been labelled with [3H]adenine and were then incubated briefly with papaverine or papaverine and prostaglandin E1. Both compounds, but particularly 2',5'-dideoxyadenosine, markedly decreased the inhibition by prostaglandin E1 of platelet aggregation induced by ADP or [arginine]
vasopressin
as well as the associated increases in platelet cyclic
AMP
, so providing further evidence that the effects of prostaglandin E1 on platelet aggregation are mediated by cyclic
AMP
. 2'-Deoxyadenosine 3'-monophosphate did not affect the inhibition of aggregation by prostaglandin E1, suggesting that the site of action of deoxyadenosine derivatives on adenylate cyclase is intracellular. Neither 2',5'-dideoxyadenosine nor compound SQ 22536 alone induced platelet aggregation. Moreover, neither compound potentiated platelet aggregation or the platelet release reaction when suboptimal concentrations of ADP, [arginine]
vasopressin
, collagen or arachidonate were added to heparinized or citrated platelet-rich plasma in the absence of prostaglandin E1. These results show that cyclic
AMP
plays no significant role in the responses of platelets to aggregating agents in the absence of compounds that increase the platelet cyclic
AMP
concentration above the resting value.
...
PMID:Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP. 21 36
PGE1 and PGE2 are known to interfere with the water permeability effect of
vasopressin
in toad bladder and kidney. It has been proposed that endogenous prostaglandin E (PGE), synthesized within cells of
vasopressin
-sensitive tissues, serves to modulate the permeability changes elicited by the
neurohypophyseal
hormone. Direct evidence in support of this hypothesis is as follows:
vasopressin
increases the biosynthesis of PGE2 in renal interstitial cells and in isolated toad bladder. In the latter, inhibition of
vasopressin
-induced synthesis of PGE by a variety of inhibitors results in a greater water permeability response to
vasopressin
. It appears that
vasopressin
has two effects in toad bladder and kidney: (i) it activates adenylate cyclase thereby increasing the concentration of adenosine 3',5' monophosphate (cyclic
AMP
), the nucleotide responsible for the resultant increase in water permeability; and (ii) it activates a phospholipase that serves to release arachidonic acid, the precursor of PGE2 from intracellular pools. The PGE derived from the arachidonic acid diminishes adenylate-cyclase activity, in consequence of which the response of the enzyme to
vasopressin
is modulated.
...
PMID:Role of prostaglandin E (PGE) in the modulation of the action of vasopressin on water flow in the urinary bladder of the toad and mammalian kidney. 21 71
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>